EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Potentials and challenges of next generation sequencing-guided individualized treatment for management of rifampicin-resistant tuberculosis – A qualitative study

Tu Pham Hien Trang iD, Antonio Barrenechea-Pulache iD, Katinka De Wet iD, Boitumelo Fanampe, Salome Charalambous, Annelies Van Rie

PLOS One · 2026

DOI: 10.1371/journal.pone.0350514 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift PLOS One, 2026. Verfasst von Tu Pham Hien Trang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine and Population Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Rifampin, High-Throughput Nucleotide Sequencing, Tuberculosis, Multidrug-Resistant, Mycobacterium tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Next generation sequencing (NGS) is a powerful technology for diagnosing and managing rifampicin-resistant tuberculosis (RR-TB). To facilitate its integration into routine RR-TB care, a treatment recommendation system was developed to automatically translate whole genome sequencing (WGS) results into treatment recommendations. The effectiveness of WGS-guided treatment recommendations was evaluated in the SMARTT trial.

Methods

We conducted a focus group discussion among eleven health care workers (HCWs) involved with managing SMARTT trial participants to explore their experiences and attitudes towards WGS-guided treatment recommendations. Thematic analysis was undertaken with an inductive approach.

Results

The use of WGS and automated treatment recommendations simplified drug susceptibility testing (DST) and was perceived as beneficial to patients and HCWs. The strategy did not negatively impact HCWs autonomy and competence. Trust and acceptance were compromised by slow turn-around time, guideline deviations, discordance between DST methods, and unfavorable outcomes of some patients. Implementation challenges included drug stock-out, limited internet connection and training requirements.

Conclusion

NGS accompanied by automated treatment recommendations holds promise for improving RR-TB care in high-burden settings, benefiting both patients and HCWs. Perspectives of policymakers, laboratory staff and patients should be explored to support the routine implementation of NGS in RR-TB management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinHigh-Throughput Nucleotide SequencingTuberculosis, Multidrug-ResistantMycobacterium tuberculosisPrecision MedicineAntitubercular AgentsHumansWhole Genome SequencingFemaleMicrobial Sensitivity TestsFocus GroupsMaleQualitative ResearchDrug Resistance, Bacterial

Substanzen

RifampinAntitubercular Agents

Autor:innen und Institutionen

  • Department of Family Medicine and Population Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Facultad de Medicina, Universidad Científica del Sur, Lima, Perú.
  • Interdisciplinary Centre for Digital Futures/ Department of Sociology, University of the Free State, Free State, South Africa.
  • Free State Department of Health, Bloemfontein, South Africa.
  • Aurum Institute, Johannesburg, South Africa.

ORCID-Profile: Tu Pham Hien Trang, Antonio Barrenechea-Pulache, Katinka De Wet

Förderung

  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Trang, T. P. H., Barrenechea-Pulache, A., De Wet, K., Fanampe, B., Charalambous, S., & Van Rie, A. (2026). Potentials and challenges of next generation sequencing-guided individualized treatment for management of rifampicin-resistant tuberculosis – A qualitative study. PLOS One. https://doi.org/10.1371/journal.pone.0350514

Vancouver

Trang TPH, Barrenechea-Pulache A, De Wet K, Fanampe B, Charalambous S, Van Rie A. Potentials and challenges of next generation sequencing-guided individualized treatment for management of rifampicin-resistant tuberculosis – A qualitative study. PLOS One. 2026. doi:10.1371/journal.pone.0350514

BibTeX
@article{Trang2026,
  author = {Trang, Tu Pham Hien and Barrenechea-Pulache, Antonio and De Wet, Katinka and Fanampe, Boitumelo and Charalambous, Salome and Van Rie, Annelies},
  title = {Potentials and challenges of next generation sequencing-guided individualized treatment for management of rifampicin-resistant tuberculosis – A qualitative study},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0350514}
}
Kostenlos starten →